VWM
MRNA icon

Venturi Wealth Management’s Moderna MRNA Stock Holding History

Venturi Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-896
Closed -$37.3K – 1357
2024
Q4 		$37.3K Buy
896
+664
+286% +$31.7K ﹤0.01% 1109
2024
Q3 		$15.5K Sell
232
-31
-12% -$2.85K ﹤0.01% 1087
2024
Q2 		$31.2K Buy
263
+111
+73% +$14K ﹤0.01% 812
2024
Q1 		$16.2K Buy
152
+25
+20% +$2.52K ﹤0.01% 799
2023
Q4 		$12.6K Buy
127
+26
+26% +$2.19K ﹤0.01% 820
2023
Q3 		$10.4K Sell
101
-37
-27% -$4.13K ﹤0.01% 802
2023
Q2 		$16.8K Sell
138
-50,478
-100% -$6.73M ﹤0.01% 581
2023
Q1 		$7.77M Buy
50,616
+3,113
+7% +$514K 0.64% 40
2022
Q4 		$8.53M Sell
47,503
-5,468
-10% -$894K 0.75% 35
2022
Q3 		$6.26M Buy
+52,971
New +$8.04M 0.6% 42

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Venturi Wealth Management's MRNA Position: Q1 2025 in Review

Venturi Wealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 896 shares — an estimated $37.3K sold.

Venturi Wealth Management first reported a position in MRNA in Q3 2022 and held it in 10 quarters. The position peaked at $8.53M in Q4 2022. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Venturi Wealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 896 Moderna shares in Q1 2025, an estimated $37.3K.
  • Venturi Wealth Management first reported a position in Moderna in Q3 2022 and held it in 10 quarters.
  • Venturi Wealth Management's Moderna position peaked at $8.53M in Q4 2022.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.